On the first point, we talk a lot around here about small public companies that get gobbled up by crypto entrepreneurs so ...

On May 6, Arcutis reported first-quarter results showed loss of 20 cents a share, which slightly beat estimates. Its sales ...

According to Benzinga Pro, Legend Biotech's peer group average for short interest as a percentage of float is 13.20%, which means the company has less short interest than most of its peers. Did you ...

Biopharma stock Sarepta Therapeutics Inc (NASDAQ:SRPT) is soaring today, up 20.6% at $22.17 at last glance. The biopharmaceutical company announced a strategic restructuring plan, laying off about 500 ...

Asian equities had a good day as Thailand, Indonesia, and Pakistan outperformed, while India posted a small loss.

Investing.com -- Maia Biotechnology Inc (NYSE: MAIA) stock surged 10% after the clinical-stage biopharmaceutical company announced the publication of promising preclinical data from its ...

The favorable market reaction indicates investor relief at management’s swift measures to rectify the company's worsening ...

Sarepta's cost-saving moves, FDA surprises, and pipeline potential position SRPT as a unique opportunity. Read here for an ...

Onconetix said its shareholders will own 10% of the combined company upon completion of the deal, slated to close in the fourth quarter, while investors in Ocuvex, which is focused on developing ...

Tony tucks into some fresh biotech stocks on that he will be keenly watching after a sector down period has left some bargains on the menu.

Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind ...

If you have $1,000 to invest right now, you may be wondering where to get started. You could buy stocks that are flying high ...